CAS: 10603-45-9; 3-Bromo-1-Methylpyrrolidine

该化合物是一种溴化的环环环化合物,其特点是在1位以甲基组取代1位,在3位以溴原子取代1位以甲基组替代的丙醇核心,这一结构使其成为有机合成的多用途中间体,特别是在制备药品,农用化学品和特殊化学品方面.溴代二苯为通过交叉或核循环替代反应进一步发挥作用提供了一个反应场所.甲基组加强了稳定性和影响消毒和电子特性,使其在良好的化学应用中有用.其定义明确的再活性和与各种反应条件的兼容性使它成为医学和合成化学研究人员的宝贵建筑.

结构式图片

相似化合物

569660-89-5 569660-97-5 939793-16-5

欧盟法规

C&L通报

合成工艺路线路线简述

    专利信息


    专利号:US-10975101-B2
    优先权日:2016-05-31
    标题:Ultra-potent vinca alkaloids: added molecular complexity further disrupts the tublin dimer-dimer interface
    发明人:BOGER DALE
    权利人:SCRIPPS RESEARCH INST
    摘要:Synthetically-derived and previously inaccessible modifications of 20′-hydroxy-vinca derivative compounds such as vinblastine, vincristine or vindesine are disclosed that are a stunning 100-fold more active than the natural product (IC 50 's 50-75 pM vs 7 nM, HCT116), and are now accessible as a result of advances in the total synthesis of the natural product. Illustrative new ultra-potent vinblastines bind tubulin with much higher affinity and likely further disrupt the tubulin head-to-tail α/β dimer-dimer interaction by virtue of the strategic placement of an added conformationally well-defined, rigid and extended C20′-urea along the adjacent protein-protein interface. Added molecular complexity was used to markedly enhance target binding and functional biological activity, and represents a general approach to improving the properties of other natural products targeting a protein-protein interaction. A pharmaceutical composition containing an ultra-potent 20′-hydroxy-vinca derivative compound and a method of treating cancerous cells with such a compound are also disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知